Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

Michael Migden; Carmen Loquai; Caroline Robert; Jean François Baurain; Nicholas Squittieri; Ramon Arntz; Jörg Dierlamm; Brigitte Dréno

doi:10.1016/j.jdin.2022.08.027

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

Michael Migden, Carmen Loquai, Caroline Robert, Jean François Baurain, Nicholas Squittieri, Ramon Arntz, Jörg Dierlamm, Brigitte Dréno

Dermatology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	31-33
Number of pages	3
Journal	JAAD International
Volume	10
DOIs	https://doi.org/10.1016/j.jdin.2022.08.027
State	Published - Mar 2023

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jdin.2022.08.027

Cite this

Migden, M., Loquai, C., Robert, C., Baurain, J. F., Squittieri, N., Arntz, R., Dierlamm, J., & Dréno, B. (2023). Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks. JAAD International, 10, 31-33. https://doi.org/10.1016/j.jdin.2022.08.027

@article{a6203021ce3f463d8ee205a77a2efe29,

title = "Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks",

author = "Michael Migden and Carmen Loquai and Caroline Robert and Baurain, {Jean Fran{\c c}ois} and Nicholas Squittieri and Ramon Arntz and J{\"o}rg Dierlamm and Brigitte Dr{\'e}no",

year = "2023",

month = mar,

doi = "10.1016/j.jdin.2022.08.027",

language = "English (US)",

volume = "10",

pages = "31--33",

journal = "JAAD International",

issn = "2666-3287",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Sonidegib improved quality of life in patients with advanced basal cell carcinoma

T2 - Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

AU - Migden, Michael

AU - Loquai, Carmen

AU - Robert, Caroline

AU - Baurain, Jean François

AU - Squittieri, Nicholas

AU - Arntz, Ramon

AU - Dierlamm, Jörg

AU - Dréno, Brigitte

PY - 2023/3

Y1 - 2023/3

UR - http://www.scopus.com/inward/record.url?scp=85142187245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142187245&partnerID=8YFLogxK

U2 - 10.1016/j.jdin.2022.08.027

DO - 10.1016/j.jdin.2022.08.027

M3 - Article

C2 - 36425794

AN - SCOPUS:85142187245

SN - 2666-3287

VL - 10

SP - 31

EP - 33

JO - JAAD International

JF - JAAD International

ER -

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this